Inventor
MINOMI KENJIROU
JP17 patents
Patents
17 patentsUS10047110B2Aug 14, 2018
RNA agents for GST-Pi gene modulation
NITTO DENKO CORP8 citations92
US10047111B2Aug 14, 2018
RNA interference agents for GST-PI gene modulation
NITTO DENKO CORP11 citations92
US9771582B2Sep 26, 2017
RNA interference compositions and methods for malignant tumors
NITTO DENKO CORP13 citations92
US9580710B2Feb 28, 2017
Methods and compositions for treating malignant tumors associated with KRAS mutation
NITTO DENKO CORP7 citations92
USRE48887EJan 11, 2022
RNA interference compositions and methods for malignant tumors
NITTO DENKO CORP2 citations83
US10023597B2Jul 17, 2018
RNA interference agents for p21 gene modulation
NITTO DENKO CORP6 citations83
US9695206B2Jul 4, 2017
RNA interference agents for P21 gene modulation
NITTO DENKO CORP6 citations83
US10358647B2Jul 23, 2019
siRNA structures for high activity and reduced off target
NITTO DENKO CORP6 citations81
US10792299B2Oct 6, 2020
Methods and compositions for treating malignant tumors associated with kras mutation
NITTO DENKO CORP3 citations72
US11926831B2Mar 12, 2024
SiRNA structures for high activity and reduced off target
NITTO DENKO CORP1 citations70
US11390871B2Jul 19, 2022
SiRNA structures for high activity and reduced off target
NITTO DENKO CORP3 citations70
USRE49431EFeb 28, 2023
RNA interference agents for GST-PI gene modulation
NITTO DENKO CORP0 citations62
USRE49229EOct 4, 2022
Methods and compositions for treating malignant tumors associated with KRAS mutation
NITTO DENKO CORP0 citations62
US11045488B2Jun 29, 2021
RNA interference agents for GST-π gene modulation
NITTO DENKO CORP0 citations62
US10780107B2Sep 22, 2020
Agent for inducing cell death, agent for suppressing cell proliferation, and pharmaceutical composition used for treatment of disease resulting from abnormal cell proliferation
NITTO DENKO CORP0 citations52
US11352628B2Jun 7, 2022
Methods and compositions for treating malignant tumors associated with KRAS mutation
NITTO DENKO CORP0 citations51
US10405749B2Sep 10, 2019
RNA agents for P21 gene modulation
NITTO DENKO CORP0 citations51